Shuo-yan Liu
No. 420, Fuma Rd
Fuzhou, 350014, China
Fuzhou, 350014, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
ASO Author Reflections: T12-Sarcopenia After Neoadjuvant Chemoimmunotherapy Predicts Poor Prognosis in Esophageal Squamous Cell Carcinoma.
Journal: Annals of surgical oncology
Published: June 02, 2026
Prognosis and risk factors for pathological non-response to neoadjuvant chemoimmunotherapy in locally advanced esophageal squamous cell carcinoma.
Journal: Frontiers in immunology
Published: February 22, 2026
Prognostic Significance of the T12-SMI Before and After Neoadjuvant Chemoimmunotherapy for Esophageal Squamous Cell Carcinoma.
Journal: Annals of surgical oncology
Published: January 23, 2026
CT imaging is a feasible method for the preoperative prediction of the main pathologic response after neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma.
Journal: Updates in surgery
Published: July 28, 2025
Neoadjuvant chemoradiotherapy versus neoadjuvant chemoimmunotherapy for esophageal squamous cell carcinoma with three-field lymph node dissection.
Journal: Langenbeck's archives of surgery
Published: April 18, 2025
Camrelizumab plus chemotherapy versus chemoradiotherapy as neoadjuvant therapy for resectable esophageal squamous cell carcinoma: Phase 2 randomized trial (REVO).
Journal: Nature communications
Published: December 05, 2024
Neoadjuvant chemoimmunotherapy versus neoadjuvant chemoradiotherapy in patients with borderline resectable esophageal squamous cell carcinoma.
Journal: Journal of translational medicine
Published: October 30, 2024
Developing and experimental validating a T cell senescence-related gene signature to predict prognosis and immunotherapeutic sensitivity in non-small cell lung cancer.
Journal: Gene
Published: September 10, 2024
Frequency and distribution pattern of lymph node metastasis after neoadjuvant chemoimmunotherapy for locally advanced esophageal squamous cell carcinoma.
Journal: Journal of cancer research and clinical oncology
Published: August 29, 2024
The advantages of preoperative 3D reconstruction over 2D-CT in thoracoscopic segmentectomy.
Journal: Updates in surgery
Published: July 23, 2024
Comparison of neoadjuvant chemoimmunotherapy and neoadjuvant chemotherapy for resectable esophageal squamous cell carcinoma: a retrospective study with 3-year survival analysis.
Journal: Journal of cancer research and clinical oncology
Published: May 28, 2024
Last Updated: 09/26/2026